Related references
Note: Only part of the references are listed.Systemic and Intrahepatic Interferon-Gamma-Inducible Protein 10 kDa Predicts the First-Phase Decline in Hepatitis C Virus RNA and Overall Viral Response to Therapy in Chronic Hepatitis C
Galia Askarieh et al.
HEPATOLOGY (2010)
Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Hepatitis C Patients with Advanced Fibrosis and Cirrhosis
Savino Bruno et al.
HEPATOLOGY (2010)
CXC Chemokine Ligand 4 (CXCL4) Is a Platelet-Derived Mediator of Experimental Liver Fibrosis
Mirko Moreno Zaldivar et al.
HEPATOLOGY (2010)
Chemokines in Liver Inflammation and Fibrosis
Hermann E. Wasmuth et al.
SEMINARS IN LIVER DISEASE (2010)
Pathogenesis of Liver Fibrosis: Modulation of Stellate Cells by Chemokines
H. E. Wasmuth et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2010)
A Practical Guide to the Management of HCV Infection Following Liver Transplantation
K. Watt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Hermann E. Wasmuth et al.
GASTROENTEROLOGY (2009)
Liver Myofibroblasts Regulate Infiltration and Positioning of Lymphocytes in Human Liver
Andrew P. Holt et al.
GASTROENTEROLOGY (2009)
Chemokines in the Immunopathogenesis of Hepatitis C Infection
Mathis Heydtmann et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
Peripheral CXCR3-Associated Chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection
Marija Zeremski et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Natural History of Post-Liver Transplantation Hepatitis C: A Review of Factors That May Influence Its Course
Juan F. Gallegos-Orozco et al.
LIVER TRANSPLANTATION (2009)
Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence
D. Micheloud et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Immune Interactions in Hepatic Fibrosis
Andrew P. Holt et al.
CLINICS IN LIVER DISEASE (2008)
Disease progression in chronic hepatitis C: Modifiable and nonmodifiable factors
Sharif B. Missiha et al.
GASTROENTEROLOGY (2008)
Intrahepatic Levels of CXCR3-Associated Chemokines Correlate With Liver Inflammation and Fibrosis in Chronic Hepatitis C
Marija Zeremski et al.
HEPATOLOGY (2008)
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies
E. Xirouchakis et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
Juan R. Larrubia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Chemokine-directed immune cell infiltration in acute and chronic liver disease
Karlin Raja Karlmark et al.
Expert Review of Gastroenterology & Hepatology (2008)
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis
Paul J. Pockros et al.
HEPATOLOGY (2007)
Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (Interferon-ribavirin therapy)
Marcus Bahra et al.
TRANSPLANTATION (2007)
Peginterferon and ribavirin for chronic hepatitis C
Jay H. Hoofnagle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging et al.
HEPATOLOGY (2006)
Interferon (IFN)-γ-inducible protein-10:: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-α2a and ribavirin for chronic hepatitis C virus infection
Ana I. Romero et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation
JM Langrehr et al.
LIVER TRANSPLANTATION (2006)
CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow
SM Curbishley et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up
UP Neumann et al.
TRANSPLANTATION (2004)
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
UP Neumann et al.
JOURNAL OF HEPATOLOGY (2004)
Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation
CE Harvey et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
L Lasagni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C
RH Wiesner et al.
LIVER TRANSPLANTATION (2003)
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
M Wali et al.
GUT (2002)
Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants
S Goddard et al.
TRANSPLANTATION (2001)
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes
A Bonacchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
